As of May 24
| +0.0002 / +0.11%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 0.83, with a high estimate of 1.00 and a low estimate of 0.65. The median estimate represents a +357.32% increase from the last price of 0.18.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.